Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
656
+59
+10% +$20.2K 0.09% 151
2026
Q1
$210K Sell
597
-84
-12% -$29.9K 0.09% 143
2025
Q4
$223K Buy
+681
New +$216K 0.1% 133
2024
Q3
– Sell
-2
Closed -$625 – 123
2024
Q2
$625 Buy
+2
New +$588 ﹤0.01% 364

Other funds holding AMGN

Chris Bulman's AMGN Position: Q2 2026 in Review

Chris Bulman increased its Amgen (AMGN) stake by 9.9% in Q2 2026, buying an estimated $20.2K and bringing the position to 656 shares worth $238K. The position accounts for 0.09% of the portfolio, ranked #151.

Chris Bulman first reported a position in AMGN in Q2 2024 and has held it in 4 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Chris Bulman held 656 shares of Amgen worth $238K as of Q2 2026.
  • Chris Bulman bought 59 Amgen shares in Q2 2026, an estimated $20.2K.
  • Amgen made up 0.09% of Chris Bulman's portfolio in Q2 2026, its #151 holding.
  • Chris Bulman first reported a position in Amgen in Q2 2024 and has held it in 4 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Chris Bulman's 13F filing for Q2 2026, filed 22 Jul 2026.